0% found this document useful (0 votes)
1K views

Medical Mycology Arthur F. Di Salvo, MD Reno, Nevada

The document provides an outline for a medical mycology course. It covers topics such as classification of fungi, morphology, epidemiology, diagnosis, and treatment of fungal infections. The objectives are to impart basic science and clinical knowledge of medically important fungi to assist in diagnosis. Diagnostic methods covered include wet mount microscopy, skin testing, serology, biopsy, culture, and DNA probes. Treatment focuses on exploiting differences between mammalian and fungal cell membranes, particularly by targeting ergosterol synthesis in fungi.

Uploaded by

blue_blooded23
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
1K views

Medical Mycology Arthur F. Di Salvo, MD Reno, Nevada

The document provides an outline for a medical mycology course. It covers topics such as classification of fungi, morphology, epidemiology, diagnosis, and treatment of fungal infections. The objectives are to impart basic science and clinical knowledge of medically important fungi to assist in diagnosis. Diagnostic methods covered include wet mount microscopy, skin testing, serology, biopsy, culture, and DNA probes. Treatment focuses on exploiting differences between mammalian and fungal cell membranes, particularly by targeting ergosterol synthesis in fungi.

Uploaded by

blue_blooded23
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
You are on page 1/ 124

MEDICAL MYCOLOGY

Arthur F. Di Salvo, MD
Reno, Nevada
Medical Mycology Outline
HOUR SUBJECT

1. Introduction, Actinomycetes
2. Yeasts, Dermatophytes
3. Filamentous Fungi, Dimorphic Fungi
4. Dimorphic Fungi
5. Opportunistic Fungi
OBJECTIVES
– To impart sufficient basic science of the
medically important fungi to assist you in
diagnosing mycotic diseases.
– To impart sufficient clinical knowledge
to raise your index of suspicion for
mycotic diseases.
•What is SAID is not HEARD

•What is HEARD is not UNDERSTOOD

•What is UNDERSTOOD is not RETAINED

•What is RETAINED is not IMPLEMENTED


• ASK QUESTIONS ANYTIME
INTRODUCTION
Fairy Ring
Mushrooms
What is Mycology?
Mycology is the study of
• Beer
• Wine
• Bread
• Cheese
• Gourmet mushrooms
• Environmental toxins
• Biodegradation
• Disease
BIOREMEDIATION

• Oil spills
• Cyanide in mining operations
• Dioxins and pesticides
• Produce organic acids, sugars
• Other commercial products
A. Classification
What is a Fungus ?

• Eukaryotic – a true nucleus


• Do not contain chlorophyll
• Have cell walls
• Produce filamentous structures
• Produce spores
Species of Fungi

• 100,000 – 200,000 species

• About 300 pathogenic for man


Kingdom Fungi
Eukaryocytes

•Ascomycota
•Basidiomycota
•Zygomycota
•Mitosporic Fungi
(Fungi Imperfecti)
KINGDOM CHARACTERISTIC EXAMPLE

     

Monera Prokaryocyte Bacteria


Actinomyces

Protista Eukaryocyte Protozoa

Fungi Eukaryocyte * Fungi

Plants Eukaryocyte Plants


Moss

Animals Eukaryocyte * Arthropods


Mammals

Man
KINGDOM CHARACTERISTIC EXAMPLE

     

Monera Prokaryocyte Bacteria


Actinomyces

Protista Eukaryocyte Protozoa

Fungi Eukaryocyte * Fungi

Plants Eukaryocyte Plants


Moss

Animals Eukaryocyte * Arthropods


Mammals

Man
SIZE COMPARISON OF PATHOGENS

Cocci 0.8 u
Bacilli 4-6 u
Spirochetes 8 - 10 u
Viruses 0.08 u
Protozoa 15 u
Nematodes 10 mm
Fungi 10 – 15 u
Actinomyces
(True Bacteria)
• Tradition
• Clinical infection resembles mycoses
• Actinomyces grow on mycotic media
• Actinomyces grow slowly (24-48 h)
• Gross colonies resemble fungi
– (rough,heaped, short aerial filaments)
• Resemble mycelia microscopically, with branched
mycelia in tissue and smears.
HANDOUT

Page 2
What is Medical Mycology ?
MYCOTIC DISEASES
(Four Types)
1. Hypersensitivity
– Allergy
2. Mycotoxicosis
– Production of toxin
3. Mycetismus (mushroom poisoning)
– Pre-formed toxin
4. Infection
Hypersensitivity

• FARMER’S LUNG – Moldy hay


• MALT WORKER’S DISEASE – Moldy barley
• CHEESE WASHER’S LUNG – Moldy cheese
• WOOD TRIMMER’S DISEASE – Moldy wood
PATHOGENIC FUNGI
• NORMAL HOST

• Systemic pathogens - 25 species


• Cutaneous pathogens - 33 species
• Subcutaneous pathogens - 10 species

• IMMUNOCOMPROMISED HOST
Opportunistic fungi - 300 species
PARASITIC STATE
1. Increased metabolic state
2. Modified metabolic pathways
3. Modified cell wall structure
– Carbohydrate content
– Lipid structure
– RNA aggregates
PATHOGENICITY OF FUNGI
1. Thermotolerance

2. Ability to survive in tissue environment

3. Ability to withstand host defenses


REVIVED INTEREST IN MYCOLOGY

1. Increased frequency of mycotic diseases


2. Increased awareness by physicians
3. Better trained laboratory personnel
4. More invasive procedures used on patients
5. Increased use of immunosuppressive drugs
6. Increase in immunosuppressive disease
7. Better laboratory diagnostic tools
B. MORPHOLOGY
MORPHOLGY
• Yeasts
• Hyphae (filamentous fungi, mycelium)
– Septate
– Coenocytic (non-septate)
• Dimorphic
– Yeast
– Mycelium
Dimorphic Fungi
• Yeast Form
• Parasitic form
• Tissue form
• Cultured at 37 C
• Mycelial Form
• Saprophytic form
• Cultured at 25 C
SPORES
• SEXUAL
• ASEXUAL
– Arthrospore
– Blastospore
– Chamydospore
– Conidia
• Microconidia
• Macroconidia
By their fruits ye shall know them

Mathew 7:20
EPIDEMIOLOGY

PAGE 3
C. EPIDEMIOLOGY
MOST MYCOTIC AGENTS

ARE SOIL SAPRPHYTES


ECOLOGICAL ASSOCIATION
PATHOGEN HUMAN SOIL
_________________________________________
Blastomyces dermatitidis 1898 1964
Cryptococcus neoformans 1894 1951
Coccidioides immitis 1900 1932
Histoplasma capsulatum 1934 1949
Mycotic Diseases Are NOT
Contagious
ESTABLISHMENT OF INFECTION WITH A MYCOTIC
AGENT DEPENDS ON

1. Inoculum size

2. Resistance of the host


THE CLINICIAN MUST DISTINGUISH
BETWEEN:

• COLONIZATION

• FUNGEMIA

• INFECTION
PORTAL OF ENTRY
MOUTH
RESPIRATORY TRACT
EYE
•SKIN
•HAIR
•NAILS
•RESPIRATORY TRACT
•GASTROINTESTINAL SKIN
TRACT
•URINARY TRACT

UROGENITAL TRACT

ANUS
COLONIZATION
MOUTH
RESPIRATORY TRACT
EYE

Multiplication of
an organism at a
given site
without harm to SKIN

the host

UROGENITAL TRACT

ANUS
INFECTION
MOUTH
RESPIRATORY TRACT
EYE

Invasion and
multiplication of
organisms in
body tissue SKIN

resulting in
local cellular
injury.
UROGENITAL TRACT

ANUS
GEOGRAPHIC DISTRIBUTION

The present ease and frequency of world-wide


travel make it more likely that physicians in the
United States will be confronted with a variety
of unfamiliar mycoses acquired in distant parts
of the country or of the world.
Endemic Mycoses

Those fungus infections with a limited


geographic distribution. They are all
caused by dimorphic fungi
PATIENT HISTORY

• Medical
• Travel
• Occupation
• Avocation
D. DIAGNOSIS
Diagnosis

1. Wet Mount
2. Skin test
3. Serology
4. Fluorescent antibody
5. Biopsy and histopathology
6. Culture
7. DNA probes
Diagnosis

1. Wet Mount
2. Skin test
3. Serology
4. Fluorescent antibody
5. Biopsy and histopathology
6. Culture
7. DNA probes
DIRECT MICROSCOPIC
OBSERVATION

• 10 % KOH

• Gentle Heat
KOH Wet Mount
Diagnosis

1. Wet Mount
2. Skin test
3. Serology
4. Fluorescent antibody
5. Biopsy and histopathology
6. Culture
7. DNA probes
SKIN TESTING
(DERMAL HYPERSENSTIVITY)

Use is limited to :

– Determine cellular defense mechanisms


– Epidemiologic studies
Diagnosis

1. Wet Mount
2. Skin test
3. Serology
4. Fluorescent antibody
5. Biopsy and histopathology
6. Culture
7. DNA probes
FUNGI ARE POOR ANTIGENS
FUNGAL SEROLOGY
ANTIBODIES
• Latex Agglutination IgM

• Immunodiffusion IgG

• Complement Fixation IgG


Most serological tests for fungi measure
antibody. Newer tests to measure
antigen are now being developed

ANTIGEN DETECTION PRESENTLY


AVAILABLE
 Cryptococcosis
 Histoplasmosis
 Aspergillosis
Diagnosis

1. Wet Mount
2. Skin test
3. Serology
4. Fluorescent antibody
5. Biopsy and histopathology
6. Culture
7. DNA probes
DIRECT FLUORESCENT ANTIBODY
CAN BE APPLIED TO

1. HISTOLOGIC SECTIONS
2. CULTURE

• Viable organisms
• Non-viable organisms
Diagnosis

1. Wet Mount
2. Skin test
3. Serology
4. Fluorescent antibody
5. Biopsy and histopathology
6. Culture
7. DNA probe
INFLAMMATORY REACTION
• Normal host
– Pyogenic
– Granulomatous
• Immunodeficient host
– Necrosis
Polymorphic Nuclear Leukocytes
Giant Cell
GMS
Diagnosis

1. Wet Mount
2. Skin test
3. Serology
4. Fluorescent antibody
5. Biopsy and histopathology
6. Culture
7. DNA probes
ISOLATION MEDIA

SABOURAUD DEXTROSE AGAR


(pH ~ 5.6)
•Plain
•With antibiotics
•With cycloheximide
INCUBATION TEMPERATURE

• 37 C - Body temperature

• 25 C - Room temperature
Diagnosis

1. Wet Mount
2. Skin test
3. Serology
4. Fluorescent antibody
5. Biopsy and histopathology
6. Culture
7. DNA probes
DNA Probes

• Rapid (1-2 Hours)


• Species specific
• Expensive
E. TREATMENT
THERAPY

Because they are eukaryotic, fungi are


biochemically similar to the human host.
Therefore it is difficult to develop
chemotherapeutic agents that will destroy the
invading fungus without harming the patient.
A BASIC TENET OF PATHOLGY :

A CAUSE OF IRREVERSIBLE CELL INJURY IS


CELL MEMBRANE DAMAGE.
IN FUNGAL THERAPY

We attempt to induce cell injury by causing the


cell membrane of the fungus to become
permeable.
PROBLEM

Finding an agent that will selectively injure fungal


cell walls without damaging the host cell.
ALL EUKARYOTIC CELLS
CONTAIN STEROLS

•Mammalian cells – cholesterol


•Fungal cells - ergosterol
Ergosterol Synthesis
Acetyl-CoA
Acetoacetyl-CoA
HMG-CoA
Mevalonic Acid
Squalene
Allylamines
Squalene-2,3-Epoxide
Lanosterol
Azoles
Morpholines
Polyenes Ergosterol
JB
PRIMARY ANTI-FUNGAL
AGENTS
1. Polyene derivatives
– Amphotericin B
– Nystatin
2. Azoles
– Ketoconazole
– Fluconazole
– Itraconazole
– Voriconazole
– Posaconazole
AMPHOTERICIN B
Mechanism of Action
• Amphotericin B binds to sterols
• Ergosterol is a constituent of the fungal cell wall
• AMB has a greater avidity for ergosterol than for
the cholesterol in the human cell wall
• Binding to the fungal cell wall alters the
permeability and the intracellular contents leak
AMPHOTERICIN B
Disadvantages
• Intravenous administration
• Thrombophlebitis
• Nephrotoxic
• Fever
• Chills
• Anemia
• Long term administration
Azoles

There are a few rare serious side effects


from Itraconazole and Fluconazole
PRIMARY ANTI-FUNGAL
AGENTS
3. Griseofulvin
4. 5-fluorocytosine (5-FC)
5. Allylamines
-Terbinafine (Lamasil)
6. Echinocandins
- Caspofungin
Griseofulvin

A slow acting drug used for skin and nail


infections. It accumulates in the stratum
corneum and prevent hyphal penetration
through these layers
5-fluorocytosine
(5-FC)
Interferes With RNA Synthesis
MECHANISMS OF ACTION
• Polyenes • Ergosterol in cell
membrane
• Azoles • Interfere with ergosterol
synthesis
• Griseofulvin • Forms a barrier to fungal
growth

• 5 - FC
• Inhibits RNA synthesis
F. Clinical Classification of Mycoses

•Cutaneous
•Subcutaneous
•Systemic
•Opportunistic
Cutaneous Mycoses

Skin, hair and nails


Rarely invade deeper tissue

Dermatophytes
Subcutaneous Mycoses

• Confined to subcutaneous tissue and rarely spread


systemically. The causative agents are soil
organisms introduced into the extremities by
trauma
Systemic Mycoses

• Involve skin and deep viscera

• May become widely disseminated

• Predilection for specific organs


OPPORTUNISTIC FUNGI

Ubiquitous saprophytes and occasional


pathogens that invade the tissues of those
patients who have:
• Predisposing diseases:
Diabetes, cancer, leukemia, etc.
• Predisposing conditions:
Agammaglobulinemia, steroid or antibiotic
therapy.
Medical Mycology Iceberg
THE ESSENTIAL ELEMENT OF
DIAGNOSIS IS:

A HIGH INDEX OF SUSPICION !


End of
Introduction

You might also like